Cargando…
Higher Starting Dose of Ciclosporin Optimized Therapeutic Levels in Patients Receiving Phenytoin for Busulfan-induced Seizure Prophylaxis
BACKGROUND : Despite understanding the drug-drug interaction between phenytoin and ciclosporin (CsA), there is no recommended CsA dosing in patients receiving phenytoin as seizure prophylaxis in busulfan-based conditioning regimens. This drug-drug interaction has resulted in patients with sub-therap...
Autores principales: | Ho, Ying Shi, Chong, Mui Fong, Ng, Vin Cci, Ho, Aloysius, Ng, Hong Yen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asia-Pacific Blood and Marrow Transplantation Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847281/ https://www.ncbi.nlm.nih.gov/pubmed/36711059 http://dx.doi.org/10.31547/bct-2020-022 |
Ejemplares similares
-
Phenytoin as seizure prophylaxis in hematopoietic stem cell transplantation with busulfan conditioning
por: Germeraad, R. S., et al.
Publicado: (2022) -
Comparison of levetiracetam with phenytoin for the prevention of intravenous busulfan-induced seizures in hematopoietic cell transplantation recipients
por: Akiyama, Kana, et al.
Publicado: (2018) -
A Comparison of Seizure Prophylaxis: Phenytoin Versus Levetiracetam
por: Fiani, Brian, et al.
Publicado: (2021) -
Comparison of Efficacy and Safety of Levetiracetam Versus Phenytoin for Post-craniotomy Seizure Prophylaxis
por: Faghihjouibari, Morteza, et al.
Publicado: (2023) -
The Concurrent Use of Phenytoin and Levetiracetam for Seizure Prophylaxis in ICU Patients: The “Arrowhead Rationale”
por: Wong, Meghan, et al.
Publicado: (2023)